UK Updates – Windsor Framework and Regulation (EU) 2023/1182 for Centralised Products
What it means for your company Batches of medicinal product, authorised through the centralised procedure (CAP), that are currently lawfully on the market in Northern Ireland may remain so until their Expiry Date However, these medicinal products cannot be moved from Northern Ireland to an EU/EEA Member State or be placed on the market in […]